The Pfizer COVID-19 vaccine is causing allergic reactions at a rate greater than “what you would expect from” other injections, says Operation Warp Speed’s chief scientific advisor
- Dr. Moncef Slaoui said that the last time he was updated on allergic reactions was on Tuesday, when there were six cases
- ‘This frequency, as it was yesterday, is higher than you would expect with other vaccines,’ he said
- There are discussions between vaccine manufacturers and the National Institutes of Health to consider carrying out clinical trials of vaccines in very allergic groups
- The potential study may look at vaccines made by Pfizer and Moderna, although the reactions have only been reported by people who received the Pfizer vaccine
Operation Warp Speed’s chief scientific adviser said on Wednesday that Pfizer’s COVID-19 vaccine is causing more allergic reactions than is normally seen with other vaccines.
Dr. Moncef Slaoui said that the last time he was updated on allergic reactions was on Tuesday, when there were six cases, CNN reported.
“This frequency, as it was yesterday, is higher than you would expect with other vaccines,” he said.
Dr. Moncef Slaoui said that the last time he was updated about allergic reactions was on Tuesday, when there were six cases of allergic reactions
Dr. Slaoui noted that the data on coronavirus immunizations are below the actual figures.
He added that there are discussions between vaccine manufacturers and the National Institutes of Health to consider carrying out clinical trials of vaccines in very allergic populations, ideally those who carry an EpiPen with them.
Getting tested can help you understand what is causing the allergic reactions, said Slaoui.
On Monday, an official at the National Institute of Allergy and Infectious Diseases told CNBC that the United States is investigating why people suffered severe allergic reactions after taking the COVID-19 vaccine.
There are discussions between vaccine manufacturers and the National Institutes of Health to consider carrying out clinical trials of vaccines in very allergic groups
A study is currently in the early planning stages and is expected to include ‘several hundred’ people with a history of severe allergic reactions, according to Alkis Togias, head of NIAID’s Division of Allergy, Asthma and Airway Biology.
Your department will conduct the study, which is expected to begin in the coming weeks.
The study can look at vaccines made by Pfizer and Moderna, although the reactions have only been reported by people who received the vaccine from Pfizer.
A New York City health worker became the sixth person known to have a “serious” allergic reaction to a COVID-19 vaccine.
Two British health professionals went into anaphylactic shock when they received it in the first week after distribution and three in Alaska also experienced similar reactions.
More than 30,000 COVID-19 vaccines have been distributed in New York City and they are the only people known to have had a reaction.